GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Nexen, Inc. (NXY) [hlAlert]

Rating:
Neutral NXY

Nexen, Inc. (NXY) rated Neutral with price target $25 by Credit Suisse

Posted on: Monday,  Dec 15, 2008  9:25 AM ET by Credit Suisse

Nexen (NXY) rated Neutral
with price target $25 by Credit Suisse.

Nexen Inc. (Nexen) is an independent, Canadian-based, global energy company. Nexen operates in four segments: oil and gas, syncrude, energy marketing and chemicals. The Company owns 7.23% of the Syncrude Joint Venture. Energy marketing includes its crude oil, natural gas, natural gas liquids and power marketing business in North America, Europe and Asia. Chemicals include operations in North America and Brazil that manufacture, market and distribute sodium chlorate, caustic soda and chlorine through the Canexus Limited Partnership. Nexen has oil and gas operations in the United Kingdom North Sea, United States Gulf of Mexico, Yemen and other international (Colombia, offshore West Africa and Norway). Nexen has a 7.23% participating interest in Syncrude. The Company?s marketing group sells third-party natural gas, crude oil, natural gas liquids and power in certain regional global markets. Nexen manufactures sodium chlorate and chlor-alkali products in Canada and Brazil.

Excellence in equity and fixed income research is a hallmark of Credit Suisse. Globally, our equity research analysts provide in-depth coverage of over 2,500 companies and engage in a knowledge-sharing, value added culture that has yielded the most insightful product for our customers and tremendous competitive results. Additionally, Credit Suisse's powerful macro-economic and debt strategy teams integrate the bank's comprehensive company research with keen market perspectives of the ever-shifting investment terrain.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/15/2008 9:25 AM Hold
None
18.19 25.00
as of 12/24/2008
1 Week down  -0.70 %
1 Month up  8.85 %
3 Months   
1 YTD up  8.85 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy